Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | FAAH | O00519 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL339543 | 0.94 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL9633210 | 0.92 | FAAH (0.59) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL28881091 | 0.86 | FAAH (0.65) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL28881086 | 0.86 | FAAH (0.65) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL2146114 | 0.84 | FAAH (0.77) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL9003387 | 0.82 | NAAA (0.41) | MEN1KMT2AFAAHMAPK1NAAA | |
| SCHEMBL3868141 | 0.82 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL115759 | 0.82 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL117494 | 0.82 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 | |
| SCHEMBL114323 | 0.82 | MEN1 (0.54) | MEN1KMT2AFAAHMAPK1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| US-5945093-A | CONSISTS OF ANIONIC AND CATIONIC SURFACTANTS, AN ACID NEUTRALIZED AMIDONAMINE, WATER INSOLUBLE POLYSILOXANE AS CONDITIONING AGENT, DECADIENE CROSSLINKED MALEIC ANHDRIDE-METHYL VINYL ETHER COPOLYMER, FREE OF POLYHYDRIC COMPOUND | AMWAY CORPORATION (US) | 1999-08-31 | — | — | US | claimed |
| EP-0275719-A2 | Ultraviolet absorbing compounds and formulations including same | Richardson-Vicks, Inc. (US) | 1988-07-27 | — | — | EP | claimed |
| US-12257335-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-25 | — | — | US | disclosed |
| US-12083212-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2024-09-10 | — | — | US | disclosed |
| US-20220023189-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-27 | — | — | US | disclosed |
| US-20220000755-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-06 | — | — | US | disclosed |
| EP-3873621-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-08 | — | — | EP | disclosed |
| CN-113164361-A | Personal care compositions | 高露洁-棕榄公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20210052478-A1 | PERSONAL CARE COMPOSITIONS | ALTUS LABS, LLC | 2021-02-25 | — | — | US | disclosed |
| WO-2020117239-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-06-11 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| US-5945093-A | CONSISTS OF ANIONIC AND CATIONIC SURFACTANTS, AN ACID NEUTRALIZED AMIDONAMINE, WATER INSOLUBLE POLYSILOXANE AS CONDITIONING AGENT, DECADIENE CROSSLINKED MALEIC ANHDRIDE-METHYL VINYL ETHER COPOLYMER, FREE OF POLYHYDRIC COMPOUND | AMWAY CORPORATION (US) | 1999-08-31 | — | — | US | disclosed |
| US-5183580-A | Containing acyclic and cyclic quaternary ammonium salts, fatty alcohols, amines, amides, glycerides, polyether | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO INC. (US) | 1993-02-02 | — | — | US | disclosed |
| US-5130035-A | Cationic fabric softener and a red coloring system with a carrier | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1992-07-14 | — | — | US | disclosed |
| US-5089148-A | Mixture of red and yellow dyes | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0275719-A3 | ULTRAVIOLET ABSORBING COMPOUNDS AND FORMULATIONS INCLUDING SAME | Richardson-Vicks, Inc. (US) | 1988-08-10 | — | — | EP | disclosed |
| EP-0275719-A2 | Ultraviolet absorbing compounds and formulations including same | Richardson-Vicks, Inc. (US) | 1988-07-27 | — | — | EP | disclosed |
| EP-0275719-A2 | Ultraviolet absorbing compounds and formulations including same | Richardson-Vicks, Inc. (US) | 1988-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | MEN1 284/4885KMT2A 756/4885FAAH 1423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.